totrombopag choline (LGD-4665)
/ Ligand, GSK
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 16, 2024
Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
(clinicaltrials.gov)
- P2 | N=23 | Completed | Sponsor: GlaxoSmithKline | Phase classification: P2a ➔ P2
Phase classification • Hematological Disorders • Immune Thrombocytopenic Purpura • Thrombocytopenic Purpura
1 to 1
Of
1
Go to page
1